US 2017/0246295 A1Published application

Alpha-tocopherol-based adjuvanted solvent for dna vaccines

AssigneeStatens Serum Institut

InventorAnders Fomsgaard

Life of this patent

Estimating the term…

Abstract

The present invention discloses a delivery system for nucleic acid vaccines comprising an emulsion of tocol and esters hereof. Vaccines and new ways of administration of DNA vaccines are disclosed.

Claims21

Dependent claims

A delivery system for nucleic acid vaccines comprising an emulsion of tocol and esters hereof.

Dependencies are inferred from the claim text.

Facts

Application: 15/512,158Filed 17 Sep 2015
Priority: DK PA 2014 0053419 Sep 2014
Published: 31 Aug 2017
Term ends: Not estimatedThe source records don’t support an estimate.

Classification19 codes

A61K 39/39
Medicinal preparations containing antigens or antibodies: characterised by the immunostimulating additives, e.g. chemical adjuvants
A61K 9/0019
Galenical forms characterised by the site of application: injectable compositions; Intramuscular, intravenous, arterial, subcutaneous…
A61K 9/107
Dispersions; Emulsions: emulsions ; Emulsion preconcentrates; Micelles
A61K 31/355
3,4-Dihydrobenzopyrans, e.g. chroman, catechin: tocopherols, e.g. vitamin E

Family

US 10,729,765 B2Related patent
US 2017/0246295 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results